Literature DB >> 10645321

Pragmatic randomised controlled trials in psychiatry.

M Hotopf1, R Churchill, G Lewis.   

Abstract

BACKGROUND: Randomised controlled trials (RCTs) are the most important method of evaluating new treatments and treatment policies. Despite this, there are relatively few large pragmatic RCTs in psychiatry. AIMS: To explore the main advantages of large pragmatic RCTs and the obstacles to performing them in psychiatry.
METHOD: A narrative review of literature on pragmatic RCTs with examples drawn from psychiatry and other medical specialities.
RESULTS: Obstacles to performing pragmatic RCTs in psychiatry include the complexity of psychiatric interventions, the complexity of outcomes used in psychiatry and the difficulties of blinding subjects and investigators to some psychiatric interventions.
CONCLUSIONS: Researchers need to frame questions in a form that is relevant to clinicians and to convince clinicians to cooperate in simple large pragmatic trials.

Entities:  

Mesh:

Year:  1999        PMID: 10645321     DOI: 10.1192/bjp.175.3.217

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  36 in total

Review 1.  Drug treatments for schizophrenia.

Authors:  C Adams; P Wilson; S Gilbody; A M Bagnall; R Lewis
Journal:  Qual Health Care       Date:  2000-03

Review 2.  Antidepressant treatment in children and adolescents: bridging the gap between efficacy and effectiveness.

Authors:  J M Zito; D J Safer
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

3.  Can current electronic systems meet drug safety and effectiveness requirements?

Authors:  Anne Holbrook; Paul Grootendorst; Don Willison; Charles Goldsmith; Rolf Sebaldt; Karim Keshavjee
Journal:  AMIA Annu Symp Proc       Date:  2005

4.  Public-academic partnerships: early intervention for psychotic disorders in a community mental health center.

Authors:  Vinod H Srihari; Nicholas J K Breitborde; Jessica Pollard; Cenk Tek; Leslie Hyman; Linda K Frisman; Thomas H McGlashan; Selby Jacobs; Scott W Woods
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

5.  First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial.

Authors:  Vinod H Srihari; Cenk Tek; Suat Kucukgoncu; Vivek H Phutane; Nicholas J K Breitborde; Jessica Pollard; Banu Ozkan; John Saksa; Barbara C Walsh; Scott W Woods
Journal:  Psychiatr Serv       Date:  2015-02-02       Impact factor: 3.084

6.  A new generation of pragmatic trials of psychosocial interventions is needed.

Authors:  M Ruggeri; A Lasalvia; C Bonetto
Journal:  Epidemiol Psychiatr Sci       Date:  2013-03-20       Impact factor: 6.892

7.  Development of the Motivation and Skills Support (MASS) social goal attainment smartphone app for (and with) people with schizophrenia.

Authors:  Daniel Fulford; Jasmine Mote; David E Gard; Kim T Mueser; Kathryn Gill; Lawrence Leung; Kara Dillaway
Journal:  J Behav Cogn Ther       Date:  2020-07-17

8.  Specialist treatment versus self-help for bulimia nervosa: a randomised controlled trial in general practice.

Authors:  Mary Alison Durand; Michael King
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

9.  Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

10.  Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974.

Authors:  Kieran Cooley; Orest Szczurko; Dan Perri; Edward J Mills; Bob Bernhardt; Qi Zhou; Dugald Seely
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.